Personal information

No personal information available

Activities

Collapse all

Employment (1)

Monash University: Melbourne, Victoria, AU

Employment
Source: Self-asserted source
Jessica Tait

Works (11)

Cholesterol-terminated cationic lipidated oligomers (CLOs) as a new class of antifungals

Journal of Materials Chemistry B
2025 | Journal article
DOI: 10.1039/D4TB02317J
Contributors: Muhammad Bilal Hassan Mahboob; Santhni Subramaniam; Jessica R. Tait; James L. Grace; Alysha G. Elliott; Holly Floyd; Johannes Zuegg; John F. Quinn; Clive A. Prestidge; Cornelia B. Landersdorfer et al.
Source: check_circle
Crossref

Providing insight into the mechanism of action of cationic lipidated oligomers using metabolomics

mSystems
2024-05-16 | Journal article
DOI: 10.1128/msystems.00093-24
Contributors: Maytham Hussein; Muhammad Bilal Hassan Mahboob; Jessica R. Tait; James L. Grace; Véronique Montembault; Laurent Fontaine; John F. Quinn; Tony Velkov; Michael R. Whittaker; Cornelia B. Landersdorfer et al.
Source: check_circle
Crossref

Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy
2024-04-03 | Journal article
DOI: 10.1128/aac.01081-23
Contributors: Jessica R. Tait; Dovile Anderson; Roger L. Nation; Darren J. Creek; Cornelia B. Landersdorfer; James E. Leggett
Source: check_circle
Crossref

Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance.

Antimicrobial agents and chemotherapy
2023-07-10 | Journal article
DOI: 10.1128/aac.00414-23
PMID: 37428034
Contributors: Tait JR; Marina Harper; Cortés-Lara S; Rogers KE; López-Causapé C; Smallman TR; Lang Y; Lee WL; Zhou J; Jürgen Bulitta et al.
Source: Self-asserted source
Jessica Tait

Development of a sustained release implant of benzathine penicillin G for secondary prophylaxis of rheumatic heart disease.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
2023-06-23 | Journal article
DOI: 10.1016/j.ejpb.2023.06.006
PMID: 37354997
Contributors: Barr RK; Barber BW; Tait JR; Landersdorfer CB; Salman S; Musk GC; Page-Sharp M; Batty KT; Kado J; Manning L et al.
Source: Self-asserted source
Jessica Tait

Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling.

The Journal of antimicrobial chemotherapy
2022-06-01 | Journal article
DOI: 10.1093/jac/dkac124
PMID: 35470370
PMC: PMC9244232
Contributors: Tait JR; Timothy Barnett; Rogers KE; Wee Leng Lee; Page-Sharp M; Laurens Manning; Boyd BJ; Jonathan R Carapetis; Roger Nation; Cornelia Landersdorfer
Source: Self-asserted source
Jessica Tait

Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling.

Antimicrobial agents and chemotherapy
2022-01-18 | Journal article
DOI: 10.1128/aac.02203-21
PMID: 35041509
PMC: PMC8923196
Contributors: Bilal H; Tait JR; Yinzhi Lang; Zhou J; Bergen PJ; Peleg AY; Jürgen Bulitta; Antonio Oliver; Nation RL; Cornelia Landersdorfer
Source: Self-asserted source
Jessica Tait

Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model.

Antibiotics (Basel, Switzerland)
2022-01-13 | Journal article
DOI: 10.3390/antibiotics11010101
PMID: 35052977
PMC: PMC8772788
Contributors: Tait JR; Bilal H; Rogers KE; Yinzhi Lang; Kim TH; Zhou J; Wallis SC; Jürgen Bulitta; Carl Kirkpatrick; Paterson DL et al.
Source: Self-asserted source
Jessica Tait

Pharmacodynamics of ceftazidime plus tobramycin combination dosage regimens against hypermutable Pseudomonas aeruginosa isolates at simulated epithelial lining fluid concentrations in a dynamic in vitro infection model.

Journal of global antimicrobial resistance
2021-05-21 | Journal article
DOI: 10.1016/j.jgar.2021.04.021
PMID: 34023531
Contributors: Tait JR; Bilal H; Kim TH; Oh A; Peleg AY; John Dallas Boyce; Oliver A; Bergen PJ; Nation RL; Landersdorfer CB
Source: Self-asserted source
Jessica Tait

Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal Clearance.

Clinical pharmacology and therapeutics
2021-03-12 | Journal article
DOI: 10.1002/cpt.2191
PMID: 33550617
Contributors: Agyeman AA; Rogers KE; Tait JR; Bergen PJ; Carl Kirkpatrick; Steven Wallis; Bulitta JB; Paterson DL; Lipman J; Nation RL et al.
Source: Self-asserted source
Jessica Tait

Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm Model.

Antimicrobial agents and chemotherapy
2020-06-23 | Journal article
DOI: 10.1128/aac.00469-20
PMID: 32366710
PMC: PMC7318014
Contributors: Bilal H; Bergen PJ; Tait JR; Steven Wallis; Peleg AY; Jason Roberts; Antonio Oliver; Nation RL; Cornelia Landersdorfer
Source: Self-asserted source
Jessica Tait

Peer review (1 review for 1 publication/grant)

Review activity for International journal of antimicrobial agents. (1)
How many people are using ORCID?